Laprituximab
规格
| Cas Number | 1622327-38-1 |
| 规格或纯度 | ≥95% |
| 纯度 | ≥95% |
| 包装 | 10mg 或 1mg 或 5mg |
产品信息
| 品牌 | 阿拉丁 |
| 过滤标签 | EGFR,JAK/STAT Signaling,Protein Tyrosine Kinase/RTK |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 生化和生理学机理 | Laprituximab (J2898A) 是一种人源化 IgG1 抗表皮生长因子受体抗体，可用于合成 ADC IMGN289。 |
| 英文描述 |
Laprituximab (J2898A) is a humanized IgG1 anti- EGFR antibody that can be used for the synthesis of ADC IMGN289. In Vivo In the H292 xenograft tumor model, the minimally effective doses of Laprituximab (J2898A) is 3 mg/kg . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Liquid |